Keyword

indication extrapolation

Description: Indication extrapolation is the regulatory practice of extending evidence for a medicine, especially a biosimilar, to an unstudied approved use.
OpenAlex ID: keywords/indication-extrapolation
2014 · Martina Weise, Pekka Kurki, et al. · Blood · 342
2007 · H. Mellstedt, D. Niederwieser, et al. · Annals of Oncology · 301
2016 · Hillel Cohen, Donna Beydoun, et al. · Advances in Therapy · 230
2017 · Jonathan Kay, Monika M Schoels, et al. · Annals of the Rheumatic Diseases · 226
2014 · Brian G. Feagan, Denis Choquette, et al. · Biologicals · 157
2016 · Shomron Ben-Horin, Niels Vande Casteele, et al. · Clinical Gastroenterology and Hepatology · 104
2017 · John Tesser, Daniel Furst, et al. · Biologics · 93
2013 · Håkan Mellstedt · European Journal of Cancer Supplements · 66
2014 · Luis H. Camacho, Craig P. Frost, et al. · Cancer Medicine · 64
2017 · Amy Hemmington, Nicola Dalbeth, et al. · Pharmacoepidemiology and Drug Safety · 63
2016 · On behalf of the CRI (Club “Rhumatismes et Inflammations”), Morgane Beck, et al. · BioDrugs · 61
2014 · Hans C. Ebbers · Journal of Crohn s and Colitis · 59
2016 · Giuseppe Curigliano, Darran P. O’Connor, et al. · Critical Reviews in Oncology/Hematology · 51
2015 · David Grabowski, Bradley Henderson, et al. · Clinical Rheumatology · 48
2018 · Barbara Melosky, David A Reardon, et al. · Future Oncology · 47
2022 · Deeksha Joshi, Rubiya Khursheed, et al. · Pharmaceutics · 45
2020 · Justin Stebbing, Paul N. Mainwaring, et al. · Journal of Clinical Oncology · 44
2016 · Massimo Radin, Savino Sciascia, et al. · BioDrugs · 42
Works count: 143
Citation count: 3,344
Year
Topic
Type